UPC_CFI_497/2024

MODULAR POINT-OF-CARE DEVICES AND USES THEREOF

RevocationMain Revocation ActionMilan CDRevocationCase Closed

2025-10-23Patent amendedrevocation_meritsRevocation Action
The Central Division Milan rejected the revocation action by bioMérieux against Labrador Diagnostics' EP 3 756 767 B1 (diagnostic test patent), maintaining the patent in amended form pursuant to Auxiliary Request 3; bioMérieux was ordered to pay EUR 400,000 in legal costs to Labrador.